SPECIAL NOTICE
We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
28 January 2021
| Name: | BPH ENERGY LTD (BPH) | |||||||||
| ISIN: | AU000000BPH4 | |||||||||
| Date of Listing: | 06 August 2004 | |||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
ACN: 095 912 002ABN: 41 095 912 002
Registration Date: 14 February 2001
Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| BPH ENERGY LTD | 24/12/2010 | |
| BPH CORPORATE LTD | 10/02/2010 | 24/12/2010 |
| BIOPHARMICA LIMITED | 10/02/2010 |
Advanced Share Registry Services, 110 Stirling Hwy, Nedlands WA 6009
Tel : +61 8 9389 8033Expand this box to read and print
The suspension of trading in the securities of BPH Energy Ltd will be lifted immediately following the release by BPH of an announcement. | 18/06/2020 |
The terms sheet in relation to a COVID-related transaction has been terminated by mutual consent with the vendor. The disclosure requirements in relation to intellectual property and testing could not be met. The application to NOPTA to enable the drilling of the Baleen drill target in the PEP11 permit offshore NSW has completed assessment and is now in the final decision phase. The placement shares have been issued. A holding lock has been placed on these shares pending completion and lodgment of a cleansing prospectus, which is currently being finalised. | 18/06/2020 |
Advent Energy limited and Asset Energy Pty Ltd have each served a notice of demand on MEC primarily in respect of costs incurred by Advent and Asset but claimed by MEC in its 30 June 2018 and 30 June 2019 annual Research and Development Tax Incentive claims with the Australian Taxation Office. The claim against MEC by Advent is $242,155.21, and by Asset $593,343.17. | 17/06/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 18th June 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 11/06/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 11th June 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 04/06/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 4th June 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 01/06/2020 |
The Company makes a request to extend the voluntary suspension period to Monday, 1st June 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 28/05/2020 |
The company lodges its March 2020 Quarter Activities Report - Amended. | 28/05/2020 |
The company lodges its Appendix 4C March 2020 Quarter Amended. | 28/05/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 28th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 27/05/2020 |
The Company makes a request to extend the voluntary suspension period to Wednesday, 27th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 22/05/2020 |
The company lodges its March 2020 Quarter Activities Report. | 21/05/2020 |
The company releases a notice of Proposed issue of Securities - BPH. | 21/05/2020 |
The company releases an Appendix 2A. | 21/05/2020 |
The company has successfully completed a placement to sophisticated investors raising $333,600 through the issue of 37,066,666 new shares. The placement shares have been issued at $0.009 per share, which represents a 12% premium to the 5-day VWAP and a 12% premium to the last close. | 21/05/2020 |
The Company makes a request to extend the voluntary suspension period to Friday, 22nd May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 20/05/2020 |
The Company makes a request to extend the voluntary suspension period to Wednesday, 20th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 18/05/2020 |
The Company makes a request to extend the voluntary suspension period to Monday, 18th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 15/05/2020 |
The Company makes a request to extend the voluntary suspension period to Friday, 15th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 12/05/2020 |
The Company makes a request to extend the voluntary suspension period to Tuesday, 12 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 11/05/2020 |
The Company makes a request to extend the voluntary suspension period to Monday, 11 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 08/05/2020 |
The Company makes a request to extend the voluntary suspension period to Friday, 8 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 07/05/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 7 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 06/05/2020 |
The Company makes a request to extend the voluntary suspension period to Wednesday, 6 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 04/05/2020 |
The company lodges an Appendix 4C - quarterly. | 01/05/2020 |
The securities of BPH Energy Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement regarding a capital raising and a new potential investment. | 30/04/2020 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 08/04/2020 |
The suspension of trading in the securities of BPH Energy Ltd will be lifted immediately following the release by BPH of an announcement regarding distribution agreement relating its investment in Patagonia Genetics Pty Ltd. | 11/12/2019 |
The company's investee, Patagonia Genetics, has recently acquired the exclusive rights to a newly discovered high CBD phenotype of the 'Carmagnola' Italian Hemp strain. | 11/12/2019 |
The securities of BPH Energy Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement regarding a distribution agreement. | 09/12/2019 |
The suspension of trading in the securities of BPH Energy Ltd will be lifted from the commencement of trading on Monday, 12 August 2019, following the release by BPH of an announcement regarding a settlement with MEC Resources Limited. | 09/08/2019 |
The company has reached a settlement with MEC Resources Limited in relation to the oppression proceedings it commenced in the Supreme Court of Western Australia earlier this year with Grandbridge, Trandcorp and Mr. David Breeze. BPH, MEC, GBA, Trandcorp and Mr. David Breeze settled a number of other proceedings and entered into a deed of settlement and release with Advent Energy and other relevant parties. | 09/08/2019 |
The securities of BPH Energy Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement. | 09/08/2019 |
The suspension of trading in the securities of BPH Energy Ltd will be lifted immediately, following the release by BPH of an announcement. | 31/10/2018 |
The company issues an entitlement issue prospectus for a non-renounceable entitlement issue of one (1) Share for every one (1) Share held by those Shareholders registered at the Record Date at an issue price of $0.001 per Share to raise up to approximately $1,186,237 | 31/10/2018 |
The company provides additional information in respect of the placement. 69,928,113 shares have been issued within its remaining 15% approval limit under Listing Rule 7.1 and 75,121,887 shares under the additional 10% approval limit approved by shareholders at the last Annual General Meeting under Listing Rule 7.1A. The shares are being issued pursuant to its 10% capacity under ASX Listing Rule 7.1A in conjunction with a rights issue announced on 25 October 2018. The issue is not underwrittten and there are no fees payable in connection with the issue. Once the Company issued the 69,928,113 ordinary shares within its remaining 15% approval limit under ASX Listing Rule 7.1 there were 1,111,115,530 ordinary shares on issue. The issue of the additional 75,121,887 ordinary shares within its 10% approval limit under ASX Listing Rule 7.1A resulted in a dilution of 6.8%. The non-cash consideration received for the 75,121,887 shares issued under Listing Rule 7.1A is set out in the valuation report lodged with ASX dated 25 October 2018. | 26/10/2018 |
The company releases a valuation report for the purposes of Listing Rule 7.1A.3. | 25/10/2018 |
The securities of BPH Energy Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement. | 25/10/2018 |
The suspension of trading in the securities of BPH Energy Ltd will be lifted immediately, following the release by BPH of an announcement and receipt of a response to an ASX Query | 25/10/2018 |
The company issues a response to ASX query. | 25/10/2018 |
The company announces a pro rata non-renounceable rights offer of one (1) new fully paid ordinary share in the capital of the Company for every one (1) Share held by eligible shareholders at an issue price of $0.001 per New Share to raise up to approximately $1,186,237. The Company is also pleased to announce it has agreed a placement of 145,050,000 Shares at $0.001 per Share. | 25/10/2018 |
The company provides a market update. The Company intends to pursue a complementary strategy of making investments in the medical cannabis sector. At this stage no specific investment has been considered. BPH has announced a rights issue to raise up to $1,186,237 by issuing up to 1,186,237,417 shares on a one for one basis at an issue price of 0.1 cents ($0.001) per share. BPH has agreed to place a further $145,050 of shares in the Company at 0.1 cents ($0.001) per share. Cortical Dynamics Limited's BAR Monitor will be exhibited by the Cortical Korean distributor GLOBALUCK on 8th to 10th November 2018 at the Congress of Korean Anaesthesiology meeting in Seoul. Cortical has engaged Enable Funding to undertake a pre-IPO capital raising of up to $2 million at a price of 10 cents per share. Cortical's BARM has now been used in further successful trials at Strathfield Private Hospital in Sydney. Strathfield is part of the Ramsay private hospital group. | 25/10/2018 |
The securities of BPH Energy Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement. | 23/10/2018 |
The suspension of trading in the securities of BPH Energy Limited will be lifted immediately following the release of an announcement. | 18/05/2018 |
Cortical has signed an agreement for distribution of its Brain Anaesthesia Response monitor in the Benelux countries: Belgium, Netherlands and Luxembourg with Innomed Benelux BV. In Korea Cortical has signed an agreement with Globaluck. Globaluck distributes cardiac and a range of medical devices to the South Korean hospital market and will now obtain the approvals required to supply the BARM to the South Korean market. This distribution agreement arose as a result of an invitation by the Australian Trade and Investment Commission to attend and present at the Austrade Korean Medtech Innovation Showcase 2016. The distribution agreement with Innomed was signed on 27th April 2018 and the Korean agreement signed on 18th April 2018. | 18/05/2018 |
The securities of BPH Energy Ltd will be suspended from quotation immediately, in accordance with Listing Rule 17.3. | 10/05/2018 |
The suspension of trading in the securities of BPH Energy Limited will be lifted before the commencement of trading on Monday, 16 April 2018, following receipt of an announcement from the Company. | 13/04/2018 |
The Writ of Summons issued by BPH and GBA against MMR claims that monies are payable by MMR, AEL and AEP for monies lent by BPH and GBA. AEP is a wholly owned subsidiary of AEL and AEL is a controlled entity of MMR. In its announcement made on 4 April 2018, MMR and AEL dispute the liability for the amounts claimed. | 13/04/2018 |
ASX has suspended the securities of BPH Energy Limited from official quotation pursuant to Listing Rule 17.3. | 13/04/2018 |
the suspension of trading in the securities of the company will be lifted immediately, following receipt of an announcement about the final logging data on the New Seaclem 1 exploration well in PEP 11 | 04/01/2011 |
the securities of the Company will be suspended from quotation immediately, at the request of the Company, pending release of an announcement in relation to New Seaclem 1, PEP 11 | 30/12/2010 |
MEC Resources Ltd investee company Advent Energy Ltd says drilling at the New Seaclem 1 well off Australia's east coast has revealed a reservoir and sea pairs consisting of high-porosity Tertiary sandstones along with several formational and intraformational seals. Advent says a seismic line oriented south-west to north-east suggests there is significant updip structural potential which has not been tested. Further seismic data is required, and the joint venture will announce additional details in due course. Advent subsidiary Asset Energy is increasing its interest in PEP11 from 25% to 85% on completion of the New Seaclem 1 well, thereby reducing Bounty Oil & Gas's interest from 75% to 15%. Advent shareholders include MEC, BPH Energy Ltd, Grandbridge Ltd and Talbot Group Investments. | 30/12/2010 |
name changed from BPH Corporate Limited | 24/12/2010 |
The suspension of trading in the securities of BPH Energy Ltd will be lifted immediately following the release by BPH of an announcement. | 18/06/2020 |
The terms sheet in relation to a COVID-related transaction has been terminated by mutual consent with the vendor. The disclosure requirements in relation to intellectual property and testing could not be met. The application to NOPTA to enable the drilling of the Baleen drill target in the PEP11 permit offshore NSW has completed assessment and is now in the final decision phase. The placement shares have been issued. A holding lock has been placed on these shares pending completion and lodgment of a cleansing prospectus, which is currently being finalised. | 18/06/2020 |
Advent Energy limited and Asset Energy Pty Ltd have each served a notice of demand on MEC primarily in respect of costs incurred by Advent and Asset but claimed by MEC in its 30 June 2018 and 30 June 2019 annual Research and Development Tax Incentive claims with the Australian Taxation Office. The claim against MEC by Advent is $242,155.21, and by Asset $593,343.17. | 17/06/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 18th June 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 11/06/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 11th June 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 04/06/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 4th June 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 01/06/2020 |
The Company makes a request to extend the voluntary suspension period to Monday, 1st June 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 28/05/2020 |
The company lodges its March 2020 Quarter Activities Report - Amended. | 28/05/2020 |
The company lodges its Appendix 4C March 2020 Quarter Amended. | 28/05/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 28th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 27/05/2020 |
The Company makes a request to extend the voluntary suspension period to Wednesday, 27th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 22/05/2020 |
The company lodges its March 2020 Quarter Activities Report. | 21/05/2020 |
The company releases a notice of Proposed issue of Securities - BPH. | 21/05/2020 |
The company releases an Appendix 2A. | 21/05/2020 |
The company has successfully completed a placement to sophisticated investors raising $333,600 through the issue of 37,066,666 new shares. The placement shares have been issued at $0.009 per share, which represents a 12% premium to the 5-day VWAP and a 12% premium to the last close. | 21/05/2020 |
The Company makes a request to extend the voluntary suspension period to Friday, 22nd May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 20/05/2020 |
The Company makes a request to extend the voluntary suspension period to Wednesday, 20th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 18/05/2020 |
The Company makes a request to extend the voluntary suspension period to Monday, 18th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 15/05/2020 |
The Company makes a request to extend the voluntary suspension period to Friday, 15th May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 12/05/2020 |
The Company makes a request to extend the voluntary suspension period to Tuesday, 12 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 11/05/2020 |
The Company makes a request to extend the voluntary suspension period to Monday, 11 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 08/05/2020 |
The Company makes a request to extend the voluntary suspension period to Friday, 8 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 07/05/2020 |
The Company makes a request to extend the voluntary suspension period to Thursday, 7 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 06/05/2020 |
The Company makes a request to extend the voluntary suspension period to Wednesday, 6 May 2020 or the Company releasing an announcement in respect to a further investment relating to COVID-19, whichever occurs earlier. | 04/05/2020 |
The company lodges an Appendix 4C - quarterly. | 01/05/2020 |
The securities of BPH Energy Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement regarding a capital raising and a new potential investment. | 30/04/2020 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 08/04/2020 |
The suspension of trading in the securities of BPH Energy Ltd will be lifted immediately following the release by BPH of an announcement regarding distribution agreement relating its investment in Patagonia Genetics Pty Ltd. | 11/12/2019 |
The company's investee, Patagonia Genetics, has recently acquired the exclusive rights to a newly discovered high CBD phenotype of the 'Carmagnola' Italian Hemp strain. | 11/12/2019 |
The securities of BPH Energy Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement regarding a distribution agreement. | 09/12/2019 |
The suspension of trading in the securities of BPH Energy Ltd will be lifted from the commencement of trading on Monday, 12 August 2019, following the release by BPH of an announcement regarding a settlement with MEC Resources Limited. | 09/08/2019 |
The company has reached a settlement with MEC Resources Limited in relation to the oppression proceedings it commenced in the Supreme Court of Western Australia earlier this year with Grandbridge, Trandcorp and Mr. David Breeze. BPH, MEC, GBA, Trandcorp and Mr. David Breeze settled a number of other proceedings and entered into a deed of settlement and release with Advent Energy and other relevant parties. | 09/08/2019 |
The securities of BPH Energy Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement. | 09/08/2019 |
The suspension of trading in the securities of BPH Energy Ltd will be lifted immediately, following the release by BPH of an announcement. | 31/10/2018 |
The company issues an entitlement issue prospectus for a non-renounceable entitlement issue of one (1) Share for every one (1) Share held by those Shareholders registered at the Record Date at an issue price of $0.001 per Share to raise up to approximately $1,186,237 | 31/10/2018 |
The company provides additional information in respect of the placement. 69,928,113 shares have been issued within its remaining 15% approval limit under Listing Rule 7.1 and 75,121,887 shares under the additional 10% approval limit approved by shareholders at the last Annual General Meeting under Listing Rule 7.1A. The shares are being issued pursuant to its 10% capacity under ASX Listing Rule 7.1A in conjunction with a rights issue announced on 25 October 2018. The issue is not underwrittten and there are no fees payable in connection with the issue. Once the Company issued the 69,928,113 ordinary shares within its remaining 15% approval limit under ASX Listing Rule 7.1 there were 1,111,115,530 ordinary shares on issue. The issue of the additional 75,121,887 ordinary shares within its 10% approval limit under ASX Listing Rule 7.1A resulted in a dilution of 6.8%. The non-cash consideration received for the 75,121,887 shares issued under Listing Rule 7.1A is set out in the valuation report lodged with ASX dated 25 October 2018. | 26/10/2018 |
The company releases a valuation report for the purposes of Listing Rule 7.1A.3. | 25/10/2018 |
The securities of BPH Energy Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement. | 25/10/2018 |
The suspension of trading in the securities of BPH Energy Ltd will be lifted immediately, following the release by BPH of an announcement and receipt of a response to an ASX Query | 25/10/2018 |
The company issues a response to ASX query. | 25/10/2018 |
The company announces a pro rata non-renounceable rights offer of one (1) new fully paid ordinary share in the capital of the Company for every one (1) Share held by eligible shareholders at an issue price of $0.001 per New Share to raise up to approximately $1,186,237. The Company is also pleased to announce it has agreed a placement of 145,050,000 Shares at $0.001 per Share. | 25/10/2018 |
The company provides a market update. The Company intends to pursue a complementary strategy of making investments in the medical cannabis sector. At this stage no specific investment has been considered. BPH has announced a rights issue to raise up to $1,186,237 by issuing up to 1,186,237,417 shares on a one for one basis at an issue price of 0.1 cents ($0.001) per share. BPH has agreed to place a further $145,050 of shares in the Company at 0.1 cents ($0.001) per share. Cortical Dynamics Limited's BAR Monitor will be exhibited by the Cortical Korean distributor GLOBALUCK on 8th to 10th November 2018 at the Congress of Korean Anaesthesiology meeting in Seoul. Cortical has engaged Enable Funding to undertake a pre-IPO capital raising of up to $2 million at a price of 10 cents per share. Cortical's BARM has now been used in further successful trials at Strathfield Private Hospital in Sydney. Strathfield is part of the Ramsay private hospital group. | 25/10/2018 |
The securities of BPH Energy Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of BPH, pending the release of an announcement. | 23/10/2018 |
The suspension of trading in the securities of BPH Energy Limited will be lifted immediately following the release of an announcement. | 18/05/2018 |
Cortical has signed an agreement for distribution of its Brain Anaesthesia Response monitor in the Benelux countries: Belgium, Netherlands and Luxembourg with Innomed Benelux BV. In Korea Cortical has signed an agreement with Globaluck. Globaluck distributes cardiac and a range of medical devices to the South Korean hospital market and will now obtain the approvals required to supply the BARM to the South Korean market. This distribution agreement arose as a result of an invitation by the Australian Trade and Investment Commission to attend and present at the Austrade Korean Medtech Innovation Showcase 2016. The distribution agreement with Innomed was signed on 27th April 2018 and the Korean agreement signed on 18th April 2018. | 18/05/2018 |
The securities of BPH Energy Ltd will be suspended from quotation immediately, in accordance with Listing Rule 17.3. | 10/05/2018 |
The suspension of trading in the securities of BPH Energy Limited will be lifted before the commencement of trading on Monday, 16 April 2018, following receipt of an announcement from the Company. | 13/04/2018 |
The Writ of Summons issued by BPH and GBA against MMR claims that monies are payable by MMR, AEL and AEP for monies lent by BPH and GBA. AEP is a wholly owned subsidiary of AEL and AEL is a controlled entity of MMR. In its announcement made on 4 April 2018, MMR and AEL dispute the liability for the amounts claimed. | 13/04/2018 |
ASX has suspended the securities of BPH Energy Limited from official quotation pursuant to Listing Rule 17.3. | 13/04/2018 |
the suspension of trading in the securities of the company will be lifted immediately, following receipt of an announcement about the final logging data on the New Seaclem 1 exploration well in PEP 11 | 04/01/2011 |
the securities of the Company will be suspended from quotation immediately, at the request of the Company, pending release of an announcement in relation to New Seaclem 1, PEP 11 | 30/12/2010 |
MEC Resources Ltd investee company Advent Energy Ltd says drilling at the New Seaclem 1 well off Australia's east coast has revealed a reservoir and sea pairs consisting of high-porosity Tertiary sandstones along with several formational and intraformational seals. Advent says a seismic line oriented south-west to north-east suggests there is significant updip structural potential which has not been tested. Further seismic data is required, and the joint venture will announce additional details in due course. Advent subsidiary Asset Energy is increasing its interest in PEP11 from 25% to 85% on completion of the New Seaclem 1 well, thereby reducing Bounty Oil & Gas's interest from 75% to 15%. Advent shareholders include MEC, BPH Energy Ltd, Grandbridge Ltd and Talbot Group Investments. | 30/12/2010 |
name changed from BPH Corporate Limited | 24/12/2010 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| David Breeze | Chairman, Managing Director | 14/02/2001 |
| Tony Huston | Director | 27/06/2017 |
| Charles Maling | Director | 17/10/2017 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Thomas Fontaine | Non Exec Director | 29/04/2015 | 17/10/2017 |
| Bruce Whan | Director | 02/02/2015 | 27/06/2017 |
| Greg Gilbert | Non Exec Director | 03/10/2007 | 02/06/2017 |
| Hock Goh | Non Exec Director | 31/10/2007 | 29/04/2015 |
| Deborah Ambrosini | Director | 31/08/2009 | 02/02/2015 |
| Seng Yap | Non Exec Director | 16/01/2004 | 26/08/2009 |
| Charles Murphy | Executive Director | 31/12/2003 | 03/10/2007 |
| Sam Gallagher | Non Exec Director | 30/11/2005 | 28/11/2006 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2021 Investogain Pty Limited. All rights reserved.
